Product NDC: | 61958-0101 |
Proprietary Name: | Vistide |
Non Proprietary Name: | CIDOFOVIR |
Active Ingredient(s): | 75 mg/mL & nbsp; CIDOFOVIR |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 61958-0101 |
Labeler Name: | Gilead Sciences, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020638 |
Marketing Category: | NDA |
Start Marketing Date: | 19960626 |
Package NDC: | 61958-0101-1 |
Package Description: | 1 VIAL, SINGLE-USE in 1 CARTON (61958-0101-1) > 5 mL in 1 VIAL, SINGLE-USE |
NDC Code | 61958-0101-1 |
Proprietary Name | Vistide |
Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (61958-0101-1) > 5 mL in 1 VIAL, SINGLE-USE |
Product NDC | 61958-0101 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | CIDOFOVIR |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19960626 |
Marketing Category Name | NDA |
Labeler Name | Gilead Sciences, Inc. |
Substance Name | CIDOFOVIR |
Strength Number | 75 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],DNA Polymerase Inhibitors [MoA],Nucleoside Analog [Chemical/Ingredient] |